NVO Competitors & Alternatives
Compare Novo-Nordisk A/S with similar stocks in the same industry
Pharmaceutical Preparations
NVO
Main Stock$36.67
Tradestie Score
62
Market Cap
$262.92B
P/E Ratio
10.4
Revenue Growth
-0.1%
Analyst Upside
+28.7%
Top Competitors
553 stocks in Pharmaceutical Preparations| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$927.06
|
$739.95B | 40.8 | 58 | Compare |
|
JNJ
Johnson & Johnson
|
$240.97
|
$448.07B | 22.0 | 64 | Compare |
|
ABBV
ABBVIE INC.
|
$206.69
|
$431.71B | 88.5 | 60 | Compare |
|
AZN
AstraZeneca PLC
|
$202.83
|
$261.56B | 31.2 | 56 | Compare |
|
NVS
Novartis AG
|
$152.84
|
$254.99B | 21.5 | 59 | Compare |
|
ABT
Abbott Laboratories
|
$102.30
|
$232.30B | 27.7 | 59 | Compare |
|
MRK
Merck & Co., Inc.
|
$120.85
|
$225.13B | 16.6 | 63 | Compare |
|
PFE
Pfizer Inc.
|
$27.83
|
$154.70B | 20.8 | 66 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$47.60
|
$121.27B | 20.6 | 61 | Compare |
|
VRTX
Vertex Pharmaceuticals Inc
|
$434.30
|
$103.64B | 28.7 | 59 | Compare |
More NVO Analysis
Data updated: Apr 06, 2026 | Industry: Pharmaceutical Preparations (SIC 2834)
553 stocks in this industry